NDA 203511 describes VALGANCICLOVIR HYDROCHLORIDE, which is a drug marketed by
Actavis Labs Fl Inc,
Ajanta Pharma Ltd,
Appco,
Aurobindo Pharma,
Granules,
Hetero Labs Ltd V,
MSN,
Aurobindo Pharma Ltd,
Cipla,
Dr Reddys,
Mylan, and
Strides Pharma, and is included in fifteen NDAs. It is available from
twenty suppliers. Additional details are available on the
VALGANCICLOVIR HYDROCHLORIDE profile page.
The generic ingredient in VALGANCICLOVIR HYDROCHLORIDE is
valganciclovir hydrochloride. There are seventeen
drug master file entries for this compound. Twenty-two
suppliers are listed for this compound. Additional details are available on the
valganciclovir hydrochloride profile page.